Skip to main content
. 2021 Jun 9;12:672521. doi: 10.3389/fimmu.2021.672521

Table 1.

Demographics.

Demographics N (%)
Number (N) 115 (100)
Median age - years (range) 71.3 (29.4 – 92.4)
Race
 Caucasian 115 (100)
AJCC stage
 IIIc 7 (6)
 M1a 6 (5)
 M1b 10 (9)
 M1c 89 (77)
 Not recorded 3 (3)
Mutational status
 BRAF V600 mutated 28 (24)
 NRAS mutations* 24 (25)
Prior systemic treatment for metastatic disease
 No prior treatment 41 (36)
 Ipilimumab 59 (51)
 Dabrafenib and Trametinib 18 (16)
 Chemotherapy 13 (11)

*Documented in 95 patient.